{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:14:27Z","timestamp":1792854867258,"version":"4.5.0"},"reference-count":256,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.addr.2021.114078","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T20:32:57Z","timestamp":1638995577000},"page":"114078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Overcoming the rising incidence and evolving mechanisms of antibiotic resistance by novel drug delivery approaches \u2013 An overview"],"prefix":"10.1016","volume":"181","author":[{"given":"Christopher K.C.","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita W.Y.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon S.Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamie","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1291-6537","authenticated-orcid":false,"given":"Margaret","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0005","doi-asserted-by":"crossref","first-page":"1345574","DOI":"10.1080\/16512235.2017.1345574","article-title":"Ancient permafrost staphylococci carry antibiotic resistance genes","volume":"28","author":"Kashuba","year":"2017","journal-title":"Microbial. Ecol. Health Disease"},{"key":"10.1016\/j.addr.2021.114078_b0010","unstructured":"WHO, WHO Report on Surveillance of Antibiotic Consumption: 2016-2018 Early implementation, US Official News 2018 Nov 13."},{"key":"10.1016\/j.addr.2021.114078_b0015","unstructured":"J. O'Neill, Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations, 2014 Dec."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and Evolution of Antibiotic Resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/jac\/dkv484","article-title":"Antibiotics: from prehistory to the present day","volume":"71","author":"Gould","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2021.114078_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.blo.0000183429.83168.07","article-title":"THE CLASSIC: penicillin as a chemotherapeutic agent, 1940","volume":"439","author":"Chain","year":"2005","journal-title":"Clin. Orthopaedics Related Res."},{"key":"10.1016\/j.addr.2021.114078_b0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","article-title":"\u201cCelbenin\u201d-resistant Staphylococci","volume":"1","author":"Jevons","year":"1961","journal-title":"Br. Med. J."},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.33321\/cdi.2000.24.59","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: a decade of results from south-western Sydney","volume":"24","author":"Gosbell","year":"2000","journal-title":"Commun. Diseases Intell."},{"key":"10.1016\/j.addr.2021.114078_b0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(75)91630-X","article-title":"Ampicillin-resistant Haemophilus influenzaetype B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin","author":"Medeiros","year":"1975","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/AAC.17.1.80","article-title":"Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae","volume":"17","author":"Markowitz","year":"1980","journal-title":"Antimicrobial. Agents Chemotherapy"},{"key":"10.1016\/j.addr.2021.114078_b0055","unstructured":"T. Saga, K. Yamaguchi, History of antimicrobial agents and resistant bacteria 52(2) (2009) 103\u2013108."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0060","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: A History","volume":"42","author":"Levine","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0065","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/AAC.42.5.1303","article-title":"Historical Yearly Usage of Vancomycin","volume":"42","author":"Kirst","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","article-title":"Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium","volume":"319","author":"Leclercq","year":"1988","journal-title":"New England J. Med."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S0950268800030478","article-title":"High-level vancomycin-resistant enterococci causing hospital infections","volume":"103","author":"Uttley","year":"1989","journal-title":"Epidemiol. Infect."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9343(98)00354-4","article-title":"The threat of vancomycin resistance","volume":"106","author":"Perl","year":"1999","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01641355","article-title":"Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens","volume":"11","author":"Knothe","year":"1983","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0090","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.micro.50.1.625","article-title":"Spontaneous Mutators in Bacteria: Insights into Pathways of Mutagenesis and Repair","volume":"50","author":"Miller","year":"1996","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.addr.2021.114078_b0095","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/clinids\/24.Supplement_1.S19","article-title":"Evolution and Dissemination of \u03b2-Lactamases Accelerated by Generations of \u03b2-Lactam Antibiotics","volume":"24","author":"Medeiros","year":"1997","journal-title":"Clin. Infect. Dis."},{"issue":"19","key":"10.1016\/j.addr.2021.114078_b0100","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM199611073351907","article-title":"Antimicrobial-Drug Resistance","volume":"335","author":"Gold","year":"1996","journal-title":"New England J. Med."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0105","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1574-6976.2011.00294.x","article-title":"Combinatorial events of insertion sequences and ICE in Gram-negative bacteria","volume":"35","author":"Toleman","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0110","doi-asserted-by":"crossref","first-page":"e8662","DOI":"10.1371\/journal.pone.0008662","article-title":"Evolution in quantum leaps: multiple combinatorial transfers of HPI and other genetic modules in Enterobacteriaceae","volume":"5","author":"Paauw","year":"2010","journal-title":"PloS One"},{"issue":"1036","key":"10.1016\/j.addr.2021.114078_b0115","first-page":"321","article-title":"The Structure of beta-Lactamases","volume":"289","author":"Ambler","year":"1980","journal-title":"Philos. Trans. Roy. Soc. London. Ser. B, Biol. Sci."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0120","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A functional classification scheme for beta-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated Functional Classification of \u03b2-Lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrobial. Agents Chemother"},{"issue":"3713","key":"10.1016\/j.addr.2021.114078_b0130","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/146837a0","article-title":"An Enzyme from Bacteria able to Destroy Penicillin","volume":"146","author":"Abraham","year":"1940","journal-title":"Nature (London)"},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-Spectrum \u03b2-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0140","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"Beta-Lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.addr.2021.114078_b0145","first-page":"15","article-title":"Mechanism of bacterial resistance to antibiotics","volume":"65","author":"Pitton","year":"1972","journal-title":"Ergeb Physiol"},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0150","first-page":"343","article-title":"The TEM-3 \u03b2-lactamase, which hydrolyzes broad-spectrum cephalosporins, is derived from the TEM-2 penicillinase by two amino acid substitutions","volume":"56","author":"Sougakoff","year":"1988","journal-title":"FEMS Microbiol. Lett."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: changing the face of ESBLs in Europe","volume":"59","author":"Livermore","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0160","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1128\/AAC.46.9.3045-3049.2002","article-title":"\u03b2-Lactamases of Kluyvera ascorbata, Probable Progenitors of Some Plasmid-Encoded CTX-M Types","volume":"46","author":"Humeniuk","year":"2002","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0165","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The New \u03b2-Lactamases","volume":"352","author":"Jacoby","year":"2005","journal-title":"New England J. Med."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0170","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","article-title":"Emergence and spread of antibiotic resistance following exposure to antibiotics","volume":"35","author":"Cant\u00f3n","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-Spectrum \u03b2-Lactamases: a Clinical Update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0180","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijantimicag.2009.11.003","article-title":"Molecular epidemiology of Escherichia coli producing CTX-M \u03b2-lactamases: the worldwide emergence of clone ST131 O25:H4","volume":"35","author":"Peirano","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/421495","article-title":"Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 \u03b2-Lactamases in New York City","volume":"39","author":"Bradford","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b0190","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/JCM.03264-15","article-title":"Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle","volume":"54","author":"Gniadek","year":"2016","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0924-8579(93)90045-7","article-title":"ARI 1: \u03b2-lactamase-mediated imipenem resistance in Acinetobacter baumannii","volume":"2","author":"Paton","year":"1993","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8","key":"10.1016\/j.addr.2021.114078_b0200","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1128\/AAC.49.8.3198-3202.2005","article-title":"Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumannii","volume":"49","author":"H\u00e9ritier","year":"2005","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b0205","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1128\/AAC.00856-09","article-title":"OXA-143, a Novel Carbapenem-Hydrolyzing Class D \u03b2-Lactamase in Acinetobacter baumannii","volume":"53","author":"Higgins","year":"2009","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0732-8893(98)00029-7","article-title":"Important and Emerging \u03b2-Lactamase-mediated Resistances in Hospital-based Pathogens: The Amp C Enzymes","volume":"31","author":"Jones","year":"1998","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0215","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/AAC.00826-13","article-title":"New \u03b2-lactamase inhibitors: a therapeutic renaissance in an MDR world","volume":"58","author":"Drawz","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b0220","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/AAC.00603-06","article-title":"High-Level Gentamicin Resistance Mediated by a Tn4001-Like Transposon in Seven Nonclonal Hospital Isolates of Streptococcus pasteurianus","volume":"51","author":"Chow","year":"2007","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"8","key":"10.1016\/j.addr.2021.114078_b0225","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.40.8.1926","article-title":"Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta-lactamase genes","volume":"40","author":"Bauernfeind","year":"1996","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drup.2006.05.005","article-title":"What's new in antibiotic resistance? Focus on beta-lactamases","volume":"9","author":"Babic","year":"2006","journal-title":"Drug Resistance Updates"},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0235","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1128\/AAC.02379-15","article-title":"Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-\u03b2-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa","volume":"60","author":"Kazmierczak","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0240","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/AAC.01451-07","article-title":"Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene","volume":"52","author":"Naas","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0245","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the Versatile \u03b2-Lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0250","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","article-title":"The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide","volume":"20","author":"Nordmann","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0255","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1128\/AAC.00961-09","article-title":"Novel Ambler Class A Carbapenem-Hydrolyzing \u03b2-Lactamase from a Pseudomonas fluorescens Isolate from the Seine River, Paris, France","volume":"54","author":"Girlich","year":"2010","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b0260","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1128\/AAC.01636-15","article-title":"Genetic and biochemical characterization of FRI-1, a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae","volume":"59","author":"Dortet","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0265","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1128\/AAC.00158-15","article-title":"Characterization of BKC-1 Class A Carbapenemase from Klebsiella pneumoniae Clinical Isolates in Brazil","volume":"59","author":"Nicoletti","year":"2015","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"134","key":"10.1016\/j.addr.2021.114078_b0270","article-title":"Identification of 76 novel B1 metallo-beta-lactamases through large-scale screening of genomic and metageonomic data","volume":"5","author":"Berglund","year":"2017","journal-title":"BioMed Central"},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0020007","article-title":"Comparative genomics of multidrug resistance in Acinetobacter baumannii","volume":"2","author":"Fournier","year":"2006","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1054\/drup.2001.0197","article-title":"Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition","volume":"4","author":"Azucena","year":"2001","journal-title":"Drug Resist. Updates"},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0285","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10156-006-0497-0","article-title":"Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes","volume":"13","author":"Barada","year":"2007","journal-title":"J. Infect. Chemother."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0290","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist. Updates"},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0295","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1128\/JCM.39.9.3115-3121.2001","article-title":"Identification of Aminoglycoside-Modifying Enzymes by Susceptibility Testing: Epidemiology of Methicillin-Resistant Staphylococcus aureus in Japan","volume":"39","author":"Ida","year":"2001","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b0300","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1128\/AAC.42.11.2889","article-title":"Diversity of Structures Carrying the High-Level Gentamicin Resistance Gene (aac6-aph2) in Enterococcus faecalis Strains Isolated in France","volume":"42","author":"Casetta","year":"1998","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2006","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0310","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AAC.27.1.84","article-title":"Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12","volume":"27","author":"Yoshimura","year":"1985","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0315","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/infdis\/154.2.289","article-title":"Emergence of Resistance to Imipenem during Therapy for Pseudomonas aeruginosa Infections","volume":"154","author":"Quinn","year":"1986","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0320","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/AAC.41.3.563","article-title":"Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC \u03b2-lactamase, and the loss of an outer membrane protein","volume":"41","author":"Bradford","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0325","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.36.9.2046","article-title":"Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa","volume":"36","author":"Livermore","year":"1992","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0330","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1128\/AAC.35.6.1093","article-title":"Association of two resistance mechanisms in a clinical isolate of Enterobacter cloace with high-level resistance to imipenem","volume":"35","author":"Lee","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.addr.2021.114078_b0335","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.32.8.1187","article-title":"Endogenous active efflux of norfloxacin in susceptible Escherichia coli","volume":"32","author":"Cohen","year":"1988","journal-title":"Antimicrobial. Agents Chemother."},{"key":"10.1016\/j.addr.2021.114078_b0340","first-page":"290","article-title":"Drug efflux as a mechanism of resistance","volume":"53","author":"William","year":"1996","journal-title":"Br. J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0345","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1389201023378454","article-title":"Outer Membranes and Efflux: The Path to Multidrug Resistance in Gram- Negative Bacteria","volume":"3","author":"Poole","year":"2002","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"s1","key":"10.1016\/j.addr.2021.114078_b0350","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1046\/j.1365-2672.92.5s1.4.x","article-title":"Active efflux, a common mechanism for biocide and antibiotic resistance","volume":"92","author":"Levy","year":"2002","journal-title":"J. Appl. Microbiol."},{"issue":"19","key":"10.1016\/j.addr.2021.114078_b0355","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/JB.185.19.5657-5664.2003","article-title":"AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity","volume":"185","author":"Yu","year":"2003","journal-title":"J. Bacteriol."},{"issue":"Suppl 2","key":"10.1016\/j.addr.2021.114078_b0360","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-199958002-00003","article-title":"Mechanisms of fluoroquinolone resistance: an update 1994\u20131998","volume":"58","author":"Piddock","year":"1999","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0365","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1128\/AAC.43.6.1523","article-title":"Nomenclature for New Tetracycline Resistance Determinants","volume":"43","author":"Levy","year":"1999","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0370","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01242-13","article-title":"In Vitro and In Vivo Antibacterial Activities of Omadacycline, a Novel Aminomethylcycline","volume":"58","author":"Macone","year":"2014","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0375","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/324626","article-title":"Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical Implications","volume":"34","author":"Leclercq","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b0380","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.41.12.2719","article-title":"Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae","volume":"41","author":"Clancy","year":"1997","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0385","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/AAC.44.9.2242-2246.2000","article-title":"Contribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0390","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/313452","article-title":"Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994\u20131995","volume":"29","author":"Shortridge","year":"1999","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b0395","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1128\/AAC.44.12.3395-3401.2000","article-title":"Two New Mechanisms of Macrolide Resistance in Clinical Strains of Streptococcus pneumoniae from Eastern Europe and North America","volume":"44","author":"Tait-Kamradt","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0400","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3201\/eid1106.040924","article-title":"Global Spread of Multiple Aminoglycoside Resistance Genes","volume":"11","author":"Yamane","year":"2005","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0405","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","article-title":"Aminoglycoside Resistance: The Emergence of Acquired 16S Ribosomal RNA Methyltransferases","volume":"30","author":"Doi","year":"2016","journal-title":"Infect. Dis. Clin. North America"},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b0410","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s10096-010-1004-1","article-title":"Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides","volume":"29","author":"Zhou","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0415","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.02108-12","article-title":"Coproduction of 16S rRNA Methyltransferase RmtD or RmtG with KPC-2 and CTX-M Group Extended-Spectrum \u03b2-Lactamases in Klebsiella pneumoniae","volume":"57","author":"Bueno","year":"2013","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b0420","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/423841","article-title":"Antimicrobial Resistance to Linezolid","volume":"39","author":"Meka","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0425","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/jmbi.1999.3247","article-title":"Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center","volume":"294","author":"Kloss","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2021.114078_b0430","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jgar.2017.10.018","article-title":"The emerging problem of linezolid-resistant enterococci","volume":"13","author":"Bi","year":"2018","journal-title":"J. Global Antimicrobial. Resistance"},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0435","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/JCM.01598-12","article-title":"Mechanisms of Linezolid Resistance among Staphylococci in a Tertiary Hospital","volume":"51","author":"Quiles-Melero","year":"2013","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b0440","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1128\/AAC.44.11.3224-3228.2000","article-title":"Genetic Characterization of vanG, a Novel Vancomycin Resistance Locus of Enterococcus faecalis","volume":"44","author":"McKessar","year":"2000","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0445","first-page":"31","article-title":"Transferable vancomycin and teicoplanin resistance in Enterococcus faecium","volume":"8","author":"Leclercq","year":"1989","journal-title":"Infect. Dis. Newsletter (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0450","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/mdr.2017.0147","article-title":"Vancomycin-Resistant Enterococci: A Review of Antimicrobial Resistance Mechanisms and Perspectives of Human and Animal Health","volume":"24","author":"Ahmed","year":"2018","journal-title":"Microbial. Drug Resistance (Larchmont, N.Y.)"},{"issue":"8","key":"10.1016\/j.addr.2021.114078_b0455","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/jb.174.8.2582-2591.1992","article-title":"The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147","volume":"174","author":"Arthur","year":"1992","journal-title":"J. Bacteriol."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0460","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1371\/journal.ppat.0030007","article-title":"Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium","volume":"3","author":"Leavis","year":"2007","journal-title":"PLoS Pathogens"},{"issue":"9259","key":"10.1016\/j.addr.2021.114078_b0465","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(00)04206-9","article-title":"Enterococcal vanB resistance locus in anaerobic bacteria in human faeces","volume":"357","author":"Stinear","year":"2001","journal-title":"Lancet (British Ed.)"},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0470","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/infdis\/167.5.1220","article-title":"The van b gene confers various levels of self-transferable resistance to vancomycin in enterococci","volume":"167","author":"Quintiliani","year":"1993","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.30.1.1","article-title":"Modification of penicillin-binding proteins as mechanisms of \u03b2-lactam resistance","volume":"30","author":"Malouin","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0480","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/AAC.17.3.364","article-title":"Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae","volume":"17","author":"Hakenbeck","year":"1980","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b0485","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","article-title":"Mosaic-Like Structure of Penicillin-Binding Protein 2 Gene (penA) in Clinical Isolates of Neisseria gonorrhoeae with Reduced Susceptibility to Cefixime","volume":"46","author":"Ameyama","year":"2002","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0490","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s000180050160","article-title":"Resistant penicillin-binding proteins","volume":"54","author":"Hakenbeck","year":"1998","journal-title":"CMLS, Cell Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0495","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1128\/AAC.00019-10","article-title":"Affinity of Ceftaroline and Other \u03b2-Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae","volume":"54","author":"Kosowska-Shick","year":"2010","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0500","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tim.2013.11.003","article-title":"The emergence of mecC methicillin-resistant Staphylococcus aureus","volume":"22","author":"Paterson","year":"2014","journal-title":"Trends Microbiol."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0505","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1128\/AAC.45.5.1323-1336.2001","article-title":"Structural Comparison of Three Types of Staphylococcal Cassette Chromosome mec Integrated in the Chromosome in Methicillin-Resistant Staphylococcus aureus","volume":"45","author":"Ito","year":"2001","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0510","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.meegid.2008.07.007","article-title":"The evolution of Staphylococcus aureus","volume":"8","author":"Deurenberg","year":"2008","journal-title":"Infect., Genet. Evolut."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0515","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/AAC.01118-08","article-title":"Novel Staphylococcal Cassette Chromosome mec Type, Tentatively Designated Type VIII, Harboring Class A mec and Type 4 ccr Gene Complexes in a Canadian Epidemic Strain of Methicillin-Resistant Staphylococcus aureus","volume":"53","author":"Zhang","year":"2009","journal-title":"Antimicrobial. Agents Chemother."},{"key":"10.1016\/j.addr.2021.114078_b0520","unstructured":"International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC), 2009."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0525","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/AAC.45.5.1480-1486.2001","article-title":"Penicillin-Binding Protein 5 and Expression of Ampicillin Resistance in Enterococcus faecium","volume":"45","author":"Rice","year":"2001","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0530","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/AAC.18.5.730","article-title":"Penicillin-binding proteins of penicillin-susceptible and intrinsically resistant Neisseria gonorrhoeae","volume":"18","author":"Dougherty","year":"1980","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0535","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1128\/AAC.32.5.706","article-title":"Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3","volume":"32","author":"Mendelman","year":"1988","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0540","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jac\/25.4.525","article-title":"Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae","volume":"25","author":"Mendelman","year":"1990","journal-title":"J. Antimicrob. Chemother."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b0545","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0550","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1128\/AAC.45.6.1693-1699.2001","article-title":"Association of Amino Acid Substitutions in Penicillin-Binding Protein 3 with \u03b2-Lactam Resistance in \u03b2-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae","volume":"45","author":"Ubukata","year":"2001","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0555","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.addr.2021.114078_b0560","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1128\/AAC.42.10.2661","article-title":"gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae","volume":"42","author":"Weigel","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0565","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/AAC.32.4.535","article-title":"Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO","volume":"32","author":"Robillard","year":"1988","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b0570","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/AAC.00147-08","article-title":"qnr Gene Nomenclature","volume":"52","author":"Jacoby","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.addr.2021.114078_b0575","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1073\/pnas.082092899","article-title":"Mechanism of Plasmid-Mediated Quinolone Resistance","volume":"99","author":"Tran","year":"2002","journal-title":"Proc. Nat. Acad. Sci. \u2013 PNAS"},{"key":"10.1016\/j.addr.2021.114078_b0580","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2016.09.001","article-title":"Plasmid-mediated quinolone resistance: Two decades on","volume":"29","author":"Rodr\u00edguez-Mart\u00ednez","year":"2016","journal-title":"Drug Resist. Updates"},{"issue":"9105","key":"10.1016\/j.addr.2021.114078_b0585","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Mart\u00ednez-Mart\u00ednez","year":"1998","journal-title":"Lancet (British Ed.)"},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/mdr.2010.0074","article-title":"Joint Effects of Topoisomerase Alterations and Plasmid-Mediated Quinolone-Resistant Determinants in Salmonella enterica Typhimurium","volume":"17","author":"Luo","year":"2011","journal-title":"Microbial. Drug Resistance (Larchmont, N.Y.)"},{"issue":"42","key":"10.1016\/j.addr.2021.114078_b0595","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.1208037109","article-title":"Structural basis for TetM-mediated tetracycline resistance","volume":"109","author":"D\u00f6nh\u00f6fer","year":"2012","journal-title":"Proc. Nat. Acad. Sci. \u2013 PNAS"},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0600","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/mBio.00543-17","article-title":"Novel Plasmid-Mediated Colistin Resistance Gene mcr-3 in Escherichia coli","volume":"8","author":"Yin","year":"2017","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0605","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0610","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1128\/AAC.01267-16","article-title":"Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015","volume":"60","author":"Castanheira","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b0615","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00338-17","article-title":"Dissemination of mcr-1 -Carrying Plasmids among Colistin-Resistant Salmonella Strains from Humans and Food-Producing Animals in Taiwan","volume":"61","author":"Chiou","year":"2017","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107426","article-title":"Phenotypic and Genotypic Characterization of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Strains: Relative Roles of mprF and dlt Operons","volume":"9","author":"Mishra","year":"2014","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b0625","doi-asserted-by":"crossref","first-page":"a026997","DOI":"10.1101\/cshperspect.a026997","article-title":"Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci","volume":"6","author":"Miller","year":"2016","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0630","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.00039-06","article-title":"Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus","volume":"50","author":"Friedman","year":"2006","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"10","key":"10.1016\/j.addr.2021.114078_b0635","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMoa1011138","article-title":"Genetic Basis for In Vivo Daptomycin Resistance in Enterococci","volume":"365","author":"Arias","year":"2011","journal-title":"New England J. Med."},{"key":"10.1016\/j.addr.2021.114078_b0640","unstructured":"World Health Organization, WHO global strategy for containment of antimicrobial resistance: executive summary, 2001 (accessed Jan 14, 2021)."},{"key":"10.1016\/j.addr.2021.114078_b0645","unstructured":"Centers for Disease Control and Prevention, (U. S.). Antibiotic resistance threats in the United States, 2013 [electronic resource] \/ U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2013."},{"key":"10.1016\/j.addr.2021.114078_b0650","unstructured":"18. CDC. Antibiotic resistance threats in the United States, 2019."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0655","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.addr.2021.114078_b0660","unstructured":"Organisation for Economic Co-operation and Development (OECD) and European Centre for Disease Prevention and Control (ECDC). Antimicrobial Resistance. Tackling the burden in the European UnionBriefing note for EU\/EEA countries, 2019."},{"key":"10.1016\/j.addr.2021.114078_b0665","unstructured":"World Health Organization. Antimicrobial resistance Fact sheet. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0670","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7326\/0003-4819-97-3-309","article-title":"Epidemiology of Nosocomial Infections Caused by Methicillin-Resistant Staphylococcus aureus","volume":"97","author":"Thompson","year":"1982","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0675","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/517478","article-title":"Methicillin-Resistant Staphylococcus aureus in Two Child Care Centers","volume":"178","author":"Adcock","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0680","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jama.281.6.517","article-title":"Multiple Antibiotic-Resistant Klebsiella and Escherichia coli in Nursing Homes","volume":"281","author":"Wiener","year":"1999","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b0685","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1469-0691.2003.00698.x","article-title":"Epidemiology of methicillin-resistant staphylococci in Europe","volume":"9","author":"Stefani","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0690","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CMR.00081-09","article-title":"Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic","volume":"23","author":"David","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178557","article-title":"The epidemiology of Staphylococcus aureus carriage in patients attending inner city sexually transmitted infections and community clinics in Calgary, Canada","volume":"12","author":"Ugarte Torres","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0700","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jiph.2016.05.010","article-title":"Molecular characterization of antimicrobial resistance genes against Staphylococcus aureus isolates from Trinidad and Tobago","volume":"10","author":"Akpaka","year":"2016","journal-title":"J. Infect. Public Health"},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b0705","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205761","article-title":"USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016","volume":"13","author":"Enstr\u00f6m","year":"2018","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0710","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3201\/eid0503.990303","article-title":"Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe","volume":"5","author":"Wegener","year":"1999","journal-title":"Emerg. Infect. Dis."},{"issue":"10","key":"10.1016\/j.addr.2021.114078_b0715","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/foods7100167","article-title":"Antibiotic-Resistant Salmonella in the Food Supply and the Potential Role of Antibiotic Alternatives for Control","volume":"7","author":"Nair","year":"2018","journal-title":"Foods"},{"key":"10.1016\/j.addr.2021.114078_b0720","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3389\/fmicb.2019.01509","article-title":"A Historical Review on Antibiotic Resistance of Foodborne Campylobacter","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0725","first-page":"5117","article-title":"Analysis of fluoroquinolones in dusts from intensive livestock farming and the co-occurrence of fluoroquinolone-resistant Escherichia coli","volume":"9","author":"Schulz","year":"2019","journal-title":"Sci. Reports"},{"key":"10.1016\/j.addr.2021.114078_b0730","unstructured":"The FAO-OIE-WHO Collaboration. Sharing responsibilities and coordinating global activities to address health risks at the animal-human-ecosystems interfaces, 2010; Available at: https:\/\/www.who.int\/influenza\/resources\/documents\/tripartite_concept_note_hanoi\/en\/."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0735","first-page":"105","article-title":"Surveillance and monitoring of antimicrobial resistance and antibiotic consumption in humans and animals","volume":"31","author":"Silley","year":"2012","journal-title":"Revue scientifique et technique (International Office of Epizootics)"},{"key":"10.1016\/j.addr.2021.114078_b0740","unstructured":"CLSI. M100. Performance Standards for Antimicrobial Susceptibility Testing, 29th ed."},{"key":"10.1016\/j.addr.2021.114078_b0745","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints \u2013 breakpoints and guidance https:\/\/www.eucast.org\/clinical_breakpoints\/."},{"key":"10.1016\/j.addr.2021.114078_b0750","doi-asserted-by":"crossref","unstructured":"C. Suetens, K. Latour, T. K\u00e4rki, E. Ricchizzi, P. Kinross, M.L. Moro et al., Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017, Euro surveillance: bulletin europ\u00e9en sur les maladies transmissibles 23(46) (2018).","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800516"},{"key":"10.1016\/j.addr.2021.114078_b0755","unstructured":"World Health Organization. Global Antimicrobial Resistance And Use Surveillance System (GLASS), 2020; Available at: https:\/\/www.who.int\/glass\/resources\/publications\/early-implementation-report-2020\/en\/."},{"key":"10.1016\/j.addr.2021.114078_b0760","unstructured":"World Health Organization, Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections including tuberculosis. Geneva: World Health Organization, 2017. Available at https:\/\/www.who.int\/medicines\/areas\/rational_use\/PPLreport_2017_09_19.pdf?ua=1."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0765","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/35.1.7","article-title":"TEM- and SHV-derived extended-spectrum \u03b2-lactamases: relationship between selection, structure and function","volume":"35","author":"Du Bois","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2021.114078_b0770","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2011, 2012 Nov 16."},{"key":"10.1016\/j.addr.2021.114078_b0775","unstructured":"Public Health England. English Surveillance Programme for Antimicrobial Utilsation and Resistance (ESPAUR) Report 2019 to 2020, 2020."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0780","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0732-8893(99)00120-0","article-title":"In vitro evaluation of cefepime and other broad-spectrum \u03b2-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samples","volume":"35","author":"Lewis","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0785","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jac\/dkl199","article-title":"In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 Study for Monitoring Antimicrobial Resistance Trends","volume":"58","author":"Rossi","year":"2006","journal-title":"J. Antimicrobial. Chemother."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0790","first-page":"237","article-title":"Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1","volume":"201","author":"Karim","year":"2001","journal-title":"FEMS Microbiol. Lett."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0795","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0732-8893(02)00466-2","article-title":"Evaluation of the in vitro activity of six broad-spectrum \u03b2-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories","volume":"44","author":"Mathai","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0800","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jgar.2014.05.008","article-title":"Antimicrobial susceptibility in hospitals in Hong Kong: The current status 2009\u20132011","volume":"2","author":"Lai","year":"2014","journal-title":"J. Global Antimicrobial. Resistance"},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0805","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jinf.2020.05.033","article-title":"Prevalence and associated factors for carriage of Enterobacteriaceae producing ESBLs or carbapenemase and methicillin-resistant Staphylococcus aureus in Hong Kong community","volume":"81","author":"Kwok","year":"2020","journal-title":"J. Infect."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0810","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jiac.2020.05.017","article-title":"CTX-M group gene distribution of extended spectrum beta-lactamase-producing Enterobacteriaceae at a Japanese Children's hospital","volume":"26","author":"Yamanaka","year":"2020","journal-title":"J. Infect. Chemother.: Off. J. Jpn. Soc. Chemother."},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b0815","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM198809153191114","article-title":"Broad-Spectrum, Transmissible \u03b2-Lactamases","volume":"319","author":"Jacoby","year":"1988","journal-title":"New England J. Med."},{"issue":"10","key":"10.1016\/j.addr.2021.114078_b0820","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1128\/AAC.44.10.2777-2783.2000","article-title":"Animal and Human Multidrug-Resistant, Cephalosporin-Resistant Salmonella Isolates Expressing a Plasmid-Mediated CMY-2 AmpC \u03b2-Lactamase","volume":"44","author":"Winokur","year":"2000","journal-title":"Antimicrobial. Agents Chemother."},{"key":"10.1016\/j.addr.2021.114078_b0825","doi-asserted-by":"crossref","unstructured":"J. McDanel, M. Schweizer, V. Crabb, R. Nelon, M. Samore, K. Khader et al., Incidence of Extended-Spectrum \u03b2-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review 38(10) (2017 Jul) 1209-1215.","DOI":"10.1017\/ice.2017.156"},{"issue":"8","key":"10.1016\/j.addr.2021.114078_b0830","doi-asserted-by":"crossref","first-page":"ofz353","DOI":"10.1093\/ofid\/ofz353","article-title":"Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States","volume":"6","author":"Tamma","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.addr.2021.114078_b0835","doi-asserted-by":"crossref","unstructured":"H. Lee, E. Yoon, D. Kim, S.H. Jeong, E.J. Won, J.H. Shin et al., Antimicrobial resistance of major clinical pathogens in South Korea, May 2016 to April 2017: first one-year report from Kor-GLASS, Euro Surveillance: Bulletin europ\u00e9en sur les maladies transmissibles 23(42) (2018 Oct).","DOI":"10.2807\/1560-7917.ES.2018.23.42.1800047"},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0840","doi-asserted-by":"crossref","first-page":"tav024","DOI":"10.1093\/jtm\/tav024","article-title":"High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia","volume":"23","author":"Barreto Miranda","year":"2016","journal-title":"J. Travel Med."},{"issue":"suppl_1","key":"10.1016\/j.addr.2021.114078_b0845","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/jtm\/taw101","article-title":"Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level","volume":"24","author":"Woerther","year":"2017","journal-title":"J. Travel Med."},{"key":"10.1016\/j.addr.2021.114078_b0850","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA.\u2013 Annual Epidemiological Report for 2019, 2019; Available at: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2019."},{"key":"10.1016\/j.addr.2021.114078_b0855","doi-asserted-by":"crossref","unstructured":"European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC). The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017. 17(2) (2019) 5598.","DOI":"10.2903\/j.efsa.2019.5598"},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0860","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/dky446","article-title":"Detection and characterization of ESBL-producing Escherichia coli expressing mcr-1 from dairy cows in China","volume":"74","author":"Zheng","year":"2019","journal-title":"J. Antimicrobial. Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0865","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/ijerph17041312","article-title":"Molecular Diversity of ESBL-Producing Escherichia coli from Foods of Animal Origin and Human Patients","volume":"17","author":"Alegr\u00eda","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0870","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijfoodmicro.2012.08.002","article-title":"Increased raw poultry meat colonization by extended spectrum beta-lactamase-producing Escherichia coli in the south of Spain","volume":"159","author":"Egea","year":"2012","journal-title":"Int. J. Food Microbiol."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b0875","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/cid\/ciaa122","article-title":"Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its \u201cSell-By Date\u201d in an Era of New Antibiotics and Regional Carbapenemase Epidemiology","volume":"71","author":"Livermore","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0880","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3201\/eid2305.162034","article-title":"Carbapenem-resistant Enterobacter cloacae in patients from the US Veterans Health Administration, 2006\u20132015","volume":"23","author":"Wilson","year":"2017","journal-title":"Emerg. Infect. Dis."},{"issue":"14","key":"10.1016\/j.addr.2021.114078_b0885","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.2015.12480","article-title":"Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012\u20132013","volume":"314","author":"Guh","year":"2015","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"10","key":"10.1016\/j.addr.2021.114078_b0890","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0895","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.addr.2021.114078_b0900","article-title":"Aztreonam\/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019","volume":"4","author":"Sader","year":"2020","journal-title":"J. Antimicrobial. Chemother."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0905","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/1469-0691.12678","article-title":"Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories","volume":"20","author":"Hrab\u00e1k","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0910","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhin.2018.06.024","article-title":"Point-prevalence survey of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci in adult inpatients in a university teaching hospital in the UK","volume":"100","author":"Wilson","year":"2018","journal-title":"J. Hospital Infect."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b0915","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1093\/jac\/dkw309","article-title":"Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting","volume":"71","author":"Otter","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0920","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12916-017-0844-2","article-title":"The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England","volume":"15","author":"Donker","year":"2017","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b0925","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhin.2016.06.019","article-title":"Active case finding for Carbapenemase Producing Enterobacteriaceae in a teaching hospital - prevalence and risk factors for colonisation","volume":"94","author":"Poole","year":"2016","journal-title":"J. Hospital Infect."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0930","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jac\/dkx471","article-title":"Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK Infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK)","volume":"73","author":"Woodford","year":"2018","journal-title":"J. Antimicrobial. Chemother."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b0935","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/cid\/cit500","article-title":"The Importance of Long-term Acute Care Hospitals in the Regional Epidemiology of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae","volume":"57","author":"Lin","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b0940","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/cid\/cit795","article-title":"An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant Enterobacteriaceae","volume":"58","author":"Schwaber","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0945","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijantimicag.2007.07.024","article-title":"Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel","volume":"30","author":"Samra","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0950","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing \u03b2-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b0955","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","article-title":"Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City: A New Threat to Our Antibiotic Armamentarium","volume":"165","author":"Bratu","year":"2005","journal-title":"Arch. Int. Med. (1960)"},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b0960","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkm129","article-title":"Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY","volume":"60","author":"Landman","year":"2007","journal-title":"J. Antimicrobial. Chemother."},{"issue":"8","key":"10.1016\/j.addr.2021.114078_b0965","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1128\/AAC.00107-16","article-title":"Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam","volume":"60","author":"Kazmierczak","year":"2016","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"10","key":"10.1016\/j.addr.2021.114078_b0970","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1093\/jac\/dkw242","article-title":"Rise and fall of KPC-producing Klebsiella pneumoniae in New York City","volume":"71","author":"Abdallah","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b0975","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","article-title":"Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study","volume":"20","author":"van Duin","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b0980","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.02636-14","article-title":"Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network","volume":"58","author":"Van Duin","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b0985","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"van Duin","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.addr.2021.114078_b0990","doi-asserted-by":"crossref","unstructured":"B. Albiger, C. Glasner, M.J. Struelens, H. Grundmann, D.L. Monnet, Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015, Euro surveillance: bulletin europ\u00e9en sur les maladies transmissibles 20(45) (2015) 17-34.","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062"},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b0995","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1099\/jmm.0.000217","article-title":"A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates","volume":"65","author":"Spyropoulou","year":"2016","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b1000","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12879-015-0996-7","article-title":"Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014","volume":"15","author":"Parisi","year":"2015","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b1005","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv086","article-title":"Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study","volume":"70","author":"Tumbarello","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b1010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154092","article-title":"Characterization and clinical impact of bloodstream infection caused by carbapenemase-producing Enterobacteriaceae in seven Latin American Countries","volume":"11","author":"Villegas","year":"2016","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b1015","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1128\/AAC.00047-11","article-title":"High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China","volume":"55","author":"Chen","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b1020","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"Yong","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b1025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/CMR.18.2.306-325.2005","article-title":"Metallo-betalactamases: the quiet before the storm?","volume":"18","author":"Walsh","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b1030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10096-014-2249-x","article-title":"Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai","volume":"34","author":"Kazi","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b1035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12864-016-2740-0","article-title":"Local transmission and global dissemination of New Delhi metallo-beta-lactamase (NDM): a whole genome analysis","volume":"17","author":"Khong","year":"2016","journal-title":"BMC Genom."},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b1040","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tim.2011.09.005","article-title":"The emerging NDM carbapenemases","volume":"19","author":"Nordmann","year":"2011","journal-title":"Trends Microbiol. (Regular ed.)"},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b1045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1473-3099(11)70059-7","article-title":"Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study","volume":"11","author":"Walsh","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b1050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3201\/eid1701.101443","article-title":"Carbapenemases in Enterobacteria, Hong Kong, China, 2009","volume":"17","author":"Chu","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b1055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b1060","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02178-17","article-title":"Spread of Plasmid-Encoded NDM-1 and GES-5 Carbapenemases among Extensively Drug-Resistant and Pandrug-Resistant Clinical Enterobacteriaceae in Durban, South Africa","volume":"62","author":"Pedersen","year":"2018","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b1065","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/mdr.2016.0152","article-title":"First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate","volume":"23","author":"Al-Agamy","year":"2017","journal-title":"Microbial. Drug Resistance (Larchmont, N.Y.)"},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b1070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207134","article-title":"Spread of GES-5 carbapenemase-producing Pseudomonas aeruginosa clinical isolates in Japan due to clonal expansion of ST235","volume":"13","author":"Hishinuma","year":"2018","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b1075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhin.2016.03.007","article-title":"Carbapenemase-producing Enterobacteriaceae in hospital wastewater: a reservoir that may be unrelated to clinical isolates","volume":"93","author":"White","year":"2016","journal-title":"J. Hospital Infect."},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b1080","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dkg416","article-title":"Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-\u03b2-lactamase","volume":"52","author":"Gales","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b1085","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/jac\/dku048","article-title":"Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009\u201311 in 14 European and Mediterranean countries","volume":"69","author":"Castanheira","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b1090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.48.1.15-22.2004","article-title":"Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae","volume":"48","author":"Poirel","year":"2004","journal-title":"Antimicrobial. Agents Chemother."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b1095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12941-016-0136-2","article-title":"Phenotypic and genotypic characteristics of carbapenem-resistant enterobacteriaceae in a tertiary-level reference hospital in Turkey","volume":"15","author":"Baran","year":"2016","journal-title":"Ann. Clin. Microbiol. Antimicrobials"},{"issue":"47","key":"10.1016\/j.addr.2021.114078_b1100","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.15585\/mmwr.mm6447a3","article-title":"Notes from the field: carbapenem-resistant Enterobacteriaceae producing OXA-48-like carbapenemases\u2014United States, 2010\u20132015","volume":"64","author":"Lyman","year":"2015","journal-title":"MMWR. Morbidity Mortality Weekly Report"},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b1105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.diagmicrobio.2018.10.004","article-title":"Diversity of resistance mechanisms in carbapenem-resistant Enterobacteriaceae at a health care system in Northern California, from 2013 to 2016","volume":"93","author":"Senchyna","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b1110","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/cid\/ciw398","article-title":"High rates of nonsusceptibility to ceftazidime-avibactam and identification of New Delhi metallo-beta-lactamase production in Enterobacteriaceae bloodstream infections at a major cancer center","volume":"63","author":"Aitken","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.addr.2021.114078_b1115","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1073\/pnas.1616248114","article-title":"Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks","volume":"114","author":"Cerqueira","year":"2017","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b1120","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bjm.2016.06.005","article-title":"Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii","volume":"47","author":"Pagano","year":"2016","journal-title":"Braz. J. Microbiol."},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b1125","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3201\/eid1506.081006","article-title":"Extensively Drug-Resistant Acinetobacter baumannii","volume":"15","author":"Doi","year":"2009","journal-title":"Emerg. Infect. Dis."},{"issue":"8","key":"10.1016\/j.addr.2021.114078_b1130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3201\/eid0808.020014","article-title":"Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan","volume":"8","author":"Hsueh","year":"2002","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b1135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b1140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12879-017-2932-5","article-title":"A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii","volume":"18","author":"Huang","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.addr.2021.114078_b1145","unstructured":"European Centre for Disease Prevention and Control. European Centre for Disease Prevention and Control. Antimicrobial Resistance Surveillance in Europe in 2014, 2015."},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b1150","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1128\/AAC.00633-13","article-title":"Spread of Carbapenem-Resistant Acinetobacter baumannii Global Clone 2 in Asia and AbaR-Type Resistance Islands","volume":"57","author":"Kim","year":"2013","journal-title":"Antimicrobial. Agents Chemother."},{"key":"10.1016\/j.addr.2021.114078_b1155","unstructured":"Public Health England. Laboratory surveillance of Acinetobacter spp. bacteraemia in England, Wales and Northern Ireland: 2017, 2018. Available at: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/701439\/hpr1418_acntbctr17.pdf"},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b1160","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3201\/eid2507.181200","article-title":"Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015","volume":"25","author":"Walters","year":"2019","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b1165","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b1170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of Mortality in Staphylococcus aureus Bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b1175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital signs: epidemiology, and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections\u2014United States","volume":"68","author":"Kourtis","year":"2019","journal-title":"MMWR. MMWR. Morbidity Mortality Weekly Report"},{"issue":"7","key":"10.1016\/j.addr.2021.114078_b1180","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/1469-0691.12705","article-title":"New epidemiology of Staphylococcus aureus infection in Asia","volume":"20","author":"Chen","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.addr.2021.114078_b1185","unstructured":"Centre for Health Protection, Hong Kong SAR, China. Hong Kong Strategy and Action Plan on Antimicrobial Resistance 2017-2022. Available at: https:\/\/www.chp.gov.hk\/files\/pdf\/amr_action_plan_eng.pdf"},{"issue":"4","key":"10.1016\/j.addr.2021.114078_b1190","first-page":"350","article-title":"Multidrug-resistant organism carriage among residents from residential care homes for the elderly in Hong Kong: a prevalence survey with stratified cluster sampling","volume":"24","author":"Chen","year":"2018","journal-title":"Hong Kong Med. J."},{"issue":"9","key":"10.1016\/j.addr.2021.114078_b1195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1469-0691.2000.00128.x","article-title":"Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making","volume":"6","author":"Acar","year":"2000","journal-title":"Clin. Microbiol. Infect."},{"key":"#cr-split#-10.1016\/j.addr.2021.114078_b1200.1","doi-asserted-by":"crossref","unstructured":"V. Piezzi, M. Gasser, A. Atkinson, A. Kronenberg, D. Vuichard-Gysin, S. Harbarth, J. Marschall, N. Buetti, Swiss Centre for Antibiotic Resistance (ANRESIS), & National Centre for Infection Control (Swissnoso), Increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018, Euro Surveillance: European Communicable Disease Bulletin 25","DOI":"10.2807\/1560-7917.ES.2020.25.35.1900575"},{"key":"#cr-split#-10.1016\/j.addr.2021.114078_b1200.2","doi-asserted-by":"crossref","unstructured":"(35) (2020) 1900575. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.35.1900575","DOI":"10.2807\/1560-7917.ES.2020.25.35.1900575"},{"issue":"12","key":"10.1016\/j.addr.2021.114078_b1205","first-page":"3268","article-title":"The changing landscape of vancomycin-resistant Enterococcus faecium in Australia: a population-level genomic study","volume":"73","author":"Lee","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.addr.2021.114078_b1210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.12809\/hkjr1715387","article-title":"A hospital-wide screening programme to control an outbreak of vancomycin-resistant enterococci in a large tertiary hospital in Hong Kong","volume":"23","author":"Lai","year":"2017","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.addr.2021.114078_b1215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2014.11.004","article-title":"Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead","volume":"85","author":"Velkov","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.114078_b1220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2019.06.038","article-title":"Local drug delivery systems in the management of periodontitis: A scientific review","volume":"307","author":"Rajeshwari","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b1225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1534734618757532","article-title":"Local Antibiotic Delivery Systems: Current and Future Applications for Diabetic Foot Infections","volume":"17","author":"Markakis","year":"2018","journal-title":"Int. J. Lower Extremity Wounds"},{"key":"10.1016\/j.addr.2021.114078_b1230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.blo.0000175122.50804.ce","article-title":"Local antibiotic delivery systems: where are we and where are we going?","volume":"437","author":"Hanssen","year":"2005","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"3","key":"10.1016\/j.addr.2021.114078_b1235","first-page":"141","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nature reviews","volume":"17","author":"Tyers","year":"2019","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.addr.2021.114078_b1240","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41429-020-0291-8","article-title":"Antibiotics in the clinical pipeline in October 2019","volume":"73","author":"Butler","year":"2020","journal-title":"J. Antibiotics"},{"issue":"11","key":"10.1016\/j.addr.2021.114078_b1245","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","article-title":"Antibiotic Adjuvants: Rescuing Antibiotics from Resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.addr.2021.114078_b1250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/cbdd.12478","article-title":"Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens","volume":"85","author":"Gill","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"issue":"43","key":"10.1016\/j.addr.2021.114078_b1255","doi-asserted-by":"crossref","first-page":"36814","DOI":"10.1021\/acsami.8b16092","article-title":"Antibacterial Micelles with Vancomycin-Mediated Targeting and pH\/Lipase-Triggered Release of Antibiotics","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"17","key":"10.1016\/j.addr.2021.114078_b1260","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1021\/acsami.7b00217","article-title":"Nanotransformation of Vancomycin Overcomes the Intrinsic Resistance of Gram-Negative Bacteria","volume":"9","author":"Fernandes","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2021.114078_b1265","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.687660","article-title":"Nanoantibiotics: Functions and Properties at the Nanoscale to Combat Antibiotic Resistance","volume":"9","author":"Mamun","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2021.114078_b1270","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fchem.2020.00286","article-title":"Nano-Based Drug Delivery or Targeting to Eradicate Bacteria for Infection Mitigation: A Review of Recent Advances","volume":"8","author":"Yeh","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2021.114078_b1275","article-title":"Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21004713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21004713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:07:14Z","timestamp":1759208834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21004713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":256,"alternative-id":["S0169409X21004713"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.114078","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming the rising incidence and evolving mechanisms of antibiotic resistance by novel drug delivery approaches \u2013 An overview","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.114078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114078"}}